Cell type deconvolution of methylated cell-free DNA at the resolution of individual reads

Journal Article (2023)
Author(s)

Pia Keukeleire (TU Delft - Pattern Recognition and Bioinformatics)

Stavros Makrodimitris (TU Delft - Pattern Recognition and Bioinformatics, Erasmus MC)

M. J.T. Reinders (TU Delft - Pattern Recognition and Bioinformatics, Leiden University Medical Center)

Research Group
Pattern Recognition and Bioinformatics
Copyright
© 2023 P. Keukeleire, S. Makrodimitris, M.J.T. Reinders
DOI related publication
https://doi.org/10.1093/nargab/lqad048
More Info
expand_more
Publication Year
2023
Language
English
Copyright
© 2023 P. Keukeleire, S. Makrodimitris, M.J.T. Reinders
Research Group
Pattern Recognition and Bioinformatics
Issue number
2
Volume number
5
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Cell-free DNA (cfDNA) are DNA fragments originating from dying cells that are detectable in bodily fluids, such as the plasma. Accelerated cell death, for example caused by disease, induces an elevated concentration of cfDNA. As a result, determining the cell type origins of cfDNA molecules can provide information about an individual's health. In this work, we aim to increase the sensitivity of methylation-based cell type deconvolution by adapting an existing method, CelFiE, which uses the methylation beta values of individual CpG sites to estimate cell type proportions. Our new method, CelFEER, instead differentiates cell types by the average methylation values within individual reads. We additionally improved the originally reported performance of CelFiE by using a new approach for finding marker regions that are differentially methylated between cell types. We show that CelFEER estimates cell type proportions with a higher correlation (r = 0.94 ± 0.04) than CelFiE (r = 0.86 ± 0.09) on simulated mixtures of cell types. Moreover, we show that the cell type proportion estimated by CelFEER can differentiate between ALS patients and healthy controls, between pregnant women in their first and third trimester, and between pregnant women with and without gestational diabetes.